Companies Cigna Group
Cigna (CI): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Cigna Group’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO vs. named peers58th pct.Of 31 peer CEOs
CEO pay, last three years
- $21,047,255FY2023
- $23,251,096FY2024
- $22,866,134FY2025
CEO total pay was $22,866,134 in fiscal 2025, down from $23,251,096 in fiscal 2024.
FY2025: salary $1,600,000 · bonus $0 · stock awards $13,929,161 · option awards $3,400,019
Executives and directors
Ann Dennison · CFOBrian Evanko · PresidentDavid Cordani · CEOEverett Neville · EVPNicole Jones · General CounselNoelle Eder · ExecutiveEric Palmer · EVPDonna F. Zarcone · Independent DirectorElder Granger, M.D · Independent DirectorEric C. Wiseman · Independent DirectorEric J. Foss · Lead Independent DirectorGeorge Kurian · Independent DirectorKathleen M. Mazzarella · Independent DirectorKimberly A. Ross · Independent DirectorMark B. McClellan, M.D., Ph.D · Independent DirectorMichael J. Hennigan · Independent DirectorNeesha Hathi · Independent DirectorPhilip O. Ozuah, M.D., Ph.D · Independent DirectorWilliam J. DeLaney · Former director (through FY2025)
Frequently asked questions
Who was the highest-paid executive at Cigna Group in fiscal 2025?
As disclosed, David Cordani (Chair and Chief Executive Officer) was the highest-paid executive at Cigna Group in fiscal 2025, with total compensation of $22,866,134.
How does Cigna Group's chief executive pay compare to its disclosed peer group?
As disclosed, David Cordani's total compensation ranked at the 58th percentile of Cigna Group's disclosed peer group.
What is Cigna Group's CEO-to-median employee pay ratio?
As disclosed, Cigna Group's CEO-to-median employee pay ratio was 310:1.
How did shareholders vote on Cigna Group's executive compensation?
As disclosed, 91.86% of shareholders supported Cigna Group's executive compensation in the latest say-on-pay vote.
How much does Cigna Group spend in total on board compensation for fiscal 2025?
As disclosed, Cigna Group reported total board compensation of $3,880,127 for fiscal 2025.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| David Cordani | $1,600,000 | $0 | $13,929,161 | $3,400,019 | $3,200,000 | $97,562 | $639,392 | $22,866,134 |
| Chair and Chief Executive Officer | ||||||||
| Eric Palmer | 346,154 | 0 | 5,056,613 | 1,650,055 | 0 | — | 5,221,938 | 12,274,760 |
| Former Executive Vice President, Enterprise Strategy, The Cigna Group, and President and Chief Executive Officer, Evernorth Health Services | ||||||||
| Brian Evanko | 1,073,077 | 0 | 5,056,613 | 1,650,055 | 2,150,000 | 14,810 | 53,846 | 9,998,401 |
| President and Chief Operating Officer | ||||||||
| Nicole Jones | 893,173 | 0 | 2,949,613 | 962,575 | 1,100,000 | 10,347 | 40,228 | 5,955,936 |
| Executive Vice President, Chief Administrative Officer, and General Counsel | ||||||||
| Ann Dennison | 773,077 | 0 | 2,307,330 | 500,064 | 1,075,000 | 0 | 36,055 | 4,691,526 |
| Executive Vice President, Chief Financial Officer | ||||||||
| Noelle Eder | 356,635 | 0 | 2,949,613 | 962,575 | 0 | 0 | 43,972 | 4,312,795 |
| Former Executive Vice President, Global Chief Information Officer | ||||||||
| Everett Neville | 800,000 | 0 | 1,685,847 | 550,018 | 1,000,000 | 0 | 38,050 | 4,073,915 |
| Executive Vice President, Strategy and Business Development | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| David Cordani | $22,866,134 | $23,251,096 | $21,047,255 | ↓ −384,962 |
| Eric Palmer | 12,274,760 | 10,430,488 | 8,929,311 | ↑ +1,844,272 |
| Brian Evanko | 9,998,401 | 10,284,632 | 7,794,857 | ↓ −286,231 |
| Nicole Jones | 5,955,936 | 5,788,162 | 5,210,016 | ↑ +167,774 |
| Ann Dennison | 4,691,526 | — | — | — |
| Noelle Eder | 4,312,795 | 5,788,463 | 5,271,134 | ↓ −1,475,668 |
| Everett Neville | 4,073,915 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
Aligning executive compensation to the achievement of enterprise goals that support our mission and our business strategy and drive innovation to improve access to and affordability of health care will result in the creation of meaningful and sustained long-term value benefiting our customers, patients, providers, clients, shareholders, and other stakeholders.
| CEO STI target (% of salary) | 200% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Pay Governance |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| David Cordani | PSU | 2025-02-28 | 4,169 | 33,350 | — | 66,700 | $10,528,971 |
| Nicole Jones | RSU | 2025-02-28 | — | — | 3,147 | — | 962,526 |
| Noelle Eder | OPTION | 2025-02-28 | — | — | 11,176 | — | 962,575 |
| David Cordani | RSU | 2025-02-28 | — | — | 11,117 | — | 3,400,190 |
| Everett Neville | PSU | 2025-02-28 | 450 | 3,597 | — | 7,194 | 1,135,614 |
| Ann Dennison | PSU | 2025-05-30 | 298 | 2,384 | — | 4,768 | 774,881 |
| David Cordani | OPTION | 2025-02-28 | — | — | 39,476 | — | 3,400,019 |
| Ann Dennison | OPTION | 2025-02-28 | — | — | 5,806 | — | 500,064 |
| Everett Neville | OPTION | 2025-02-28 | — | — | 6,386 | — | 550,018 |
| Everett Neville | RSU | 2025-02-28 | — | — | 1,799 | — | 550,233 |
| Ann Dennison | PSU | 2025-02-28 | 409 | 3,270 | — | 6,540 | 1,032,376 |
| Brian Evanko | OPTION | 2025-02-28 | — | — | 19,158 | — | 1,650,055 |
| Eric Palmer | OPTION | 2025-02-28 | — | — | 19,158 | — | 1,650,055 |
| Ann Dennison | RSU | 2025-02-28 | — | — | 1,635 | — | 500,073 |
| Noelle Eder | PSU | 2025-02-28 | 787 | 6,294 | — | 12,588 | 1,987,087 |
| Brian Evanko | RSU | 2025-02-28 | — | — | 5,395 | — | 1,650,088 |
| Nicole Jones | OPTION | 2025-02-28 | — | — | 11,176 | — | 962,575 |
| Eric Palmer | RSU | 2025-02-28 | — | — | 5,395 | — | 1,650,088 |
| Noelle Eder | RSU | 2025-02-28 | — | — | 3,147 | — | 962,526 |
| Nicole Jones | PSU | 2025-02-28 | 787 | 6,294 | — | 12,588 | 1,987,087 |
| Eric Palmer | PSU | 2025-02-28 | 1,349 | 10,790 | — | 21,580 | 3,406,525 |
| Brian Evanko | PSU | 2025-02-28 | 1,349 | 10,790 | — | 21,580 | 3,406,525 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| David Cordani | $3,400,190 | $10,528,971 | $3,400,019 | 60.8% |
| Nicole Jones | 962,526 | 1,987,087 | 962,575 | 50.8% |
| Noelle Eder | 962,526 | 1,987,087 | 962,575 | 50.8% |
| Everett Neville | 550,233 | 1,135,614 | 550,018 | 50.8% |
| Ann Dennison | 500,073 | 1,807,257 | 500,064 | 64.4% |
| Brian Evanko | 1,650,088 | 3,406,525 | 1,650,055 | 50.8% |
| Eric Palmer | 1,650,088 | 3,406,525 | 1,650,055 | 50.8% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Everett Neville | Option | 2,196 | 294.61 | — |
| Ann Dennison | RSU | 2,626 | — | 722,754 |
| Nicole Jones | Option | 3,487 | 294.61 | — |
| Ann Dennison | Option | 3,610 | 336.48 | — |
| Everett Neville | Option | 4,061 | 336.48 | — |
| Brian Evanko | Option | 5,423 | 294.61 | — |
| Ann Dennison | Option | 5,806 | 305.86 | — |
| Everett Neville | RSU | 6,111 | — | 1,681,931 |
| Eric Palmer | Option | 6,226 | 336.48 | — |
| Everett Neville | Option | 6,386 | 305.86 | — |
| Eric Palmer | Option | 6,386 | 305.86 | — |
| Nicole Jones | Option | 6,452 | 336.48 | — |
| Eric Palmer | Option | 6,534 | 294.61 | — |
| Everett Neville | PSU | 6,941 | — | 1,910,371 |
| Ann Dennison | PSU | 8,626 | — | 2,374,134 |
| Nicole Jones | RSU | 9,996 | — | 2,751,199 |
| Nicole Jones | Option | 11,176 | 305.86 | — |
| Eric Palmer | RSU | 11,260 | — | 3,099,090 |
| Nicole Jones | PSU | 11,607 | — | 3,194,595 |
| Brian Evanko | Option | 12,452 | 336.48 | — |
| David Cordani | Option | 13,380 | 294.61 | — |
| Brian Evanko | RSU | 16,709 | — | 4,598,818 |
| Brian Evanko | Option | 19,158 | 305.86 | — |
| Brian Evanko | PSU | 21,044 | — | 5,791,940 |
| David Cordani | Option | 24,108 | 336.48 | — |
| David Cordani | Option | 39,476 | 305.86 | — |
| David Cordani | RSU | 45,144 | — | 12,424,983 |
| David Cordani | PSU | 63,130 | — | 17,375,270 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Eric C. WisemanIndependent · Corporate Governance · People Resources | $195,000 | $215,000 | $0 | — | $306 | $410,306 |
| Elder Granger, M.DIndependent | 145,000 | 215,000 | 0 | — | 10,306 | 370,306 |
| Donna F. ZarconeIndependent · Corporate Governance · Audit · Finance & Technology · People Resources | 145,000 | 215,000 | 0 | — | 2,806 | 362,806 |
| Kimberly A. RossIndependent · Finance · Audit (Chair) · Corporate Governance · People Resources | 145,000 | 215,000 | 0 | — | 2,806 | 362,806 |
| Eric J. FossIndependent · Lead Independent Director · Finance · People Resources · Corporate Governance · Compensation | 145,000 | 215,000 | 0 | — | 306 | 360,306 |
| Kathleen M. MazzarellaIndependent · Finance & Technology · People Resources · Audit · Compensation (Chair) | 145,000 | 215,000 | 0 | — | 306 | 360,306 |
| Neesha HathiIndependent · Finance · Audit · People Resources | 120,000 | 215,000 | 0 | — | 2,806 | 337,806 |
| Philip O. Ozuah, M.D., Ph.DIndependent · Compliance · People Resources · Corporate Governance · Finance & Technology · Compensation | 120,000 | 215,000 | 0 | — | 306 | 335,306 |
| George KurianIndependent · Compliance · People Resources · Corporate Governance · Finance · Compensation | 120,000 | 215,000 | 0 | — | 306 | 335,306 |
| Mark B. McClellan, M.D., Ph.DIndependent · Audit & Compliance · Finance & Technology | 120,000 | 215,000 | 0 | — | 306 | 335,306 |
| Michael J. HenniganIndependent · Corporate Governance · Audit · Finance & Technology · People Resources · Partial-year service · Newly elected | 60,000 | 179,167 | 0 | — | 306 | 239,473 |
| William J. DeLaneyIndependent · Departed during FY | 60,000 | 0 | 0 | — | 10,094 | 70,094 |
| Brian C. EvankoEmployee director · Partial-year service · Newly elected | 0 | 0 | 0 | — | 0 | 0 |
| David M. CordaniEmployee director · Board Chair · Executive (Chair) | 0 | 0 | 0 | — | 0 | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $120,000 |
|---|---|
| Annual equity retainer | $190,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | — |
| Stock ownership guideline | $600,000 |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $1,520,000 |
| Equity awards (grant-date value) | $2,329,167 |
| All other compensation | $30,960 |
| Total cost of the board | $3,880,127 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Cigna as a peer
Companies that benchmark against CI
19 companies name CI as a compensation peer
- AMERICAN INTERNATIONAL GROUP, INC.AIGFY2025
- Archer-Daniels-Midland CoADMFY2025
- CARDINAL HEALTH INCCAHFY2026
- Cencora, Inc.CORFY2025
- CENTENE CORPCNCFY2025
- Chubb LtdCBFY2025
- CVS HEALTH CorpCVSFY2025
- Elevance Health, Inc.ELVFY2025
- HCA Healthcare, Inc.HCAFY2025
- HUMANA INCHUMFY2025
- MCKESSON CORPMCKFY2026
- METLIFE INCMETFY2025
- MOLINA HEALTHCARE, INC.MOHFY2025
- TARGET CORPTGTFY2025
- UNITEDHEALTH GROUP INCUNHFY2025
- Unum GroupUNMFY2025
- Walgreens Boots Alliance, Inc.WBAFY2024
Each company listed discloses CI in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named CI in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
C Citigroup Inc.FDX FedEx CorporationVZ Verizon Communications Inc.ELV Elevance Health, Inc.DVA DaVita Inc.DGX Quest Diagnostics IncorporatedTMUS T-Mobile US, Inc.LOW Lowe's Companies, Inc.SYY Sysco CorporationT AT&T Inc.CAH Cardinal Health, Inc.COR Cencora, Inc.CNC Centene CorporationCOST Costco Wholesale CorporationCVS CVS Health CorporationHCA HCA Healthcare, Inc.HUM Humana Inc.KR The Kroger Co.MCK McKesson CorporationMET MetLife, Inc.PRU Prudential Financial, Inc.TGT Target CorporationUNH UnitedHealth Group IncorporatedUPS United Parcel Service, Inc.WFC Wells Fargo & CompanyWBA Walgreens Boots Alliance, Inc.HSIC Henry Schein, Inc. Laboratory Corporation of America HoldingsMOH Molina Healthcare, Inc.UHS Universal Health Services, Inc. Enterprise Incentive Plan
Peer reciprocity
Of the companies Cigna Group names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
— Citigroup Inc. (C)130 FedEx Corporation (FDX)— Verizon Communications Inc. (VZ)131✓ Elevance Health, Inc. (ELV)132— DaVita Inc. (DVA)133— Quest Diagnostics Incorporated (DGX)134— T-Mobile US, Inc. (TMUS)135— Lowe's Companies, Inc. (LOW)136— Sysco Corporation (SYY)137— AT&T Inc. (T)138✓ Cardinal Health, Inc. (CAH)139✓ Cencora, Inc. (COR)140✓ Centene Corporation (CNC)141— Costco Wholesale Corporation (COST)142 CVS Health Corporation (CVS)✓ HCA Healthcare, Inc. (HCA)143✓ Humana Inc. (HUM)144 The Kroger Co. (KR) McKesson Corporation (MCK) MetLife, Inc. (MET)— Prudential Financial, Inc. (PRU)145✓ Target Corporation (TGT)146✓ UnitedHealth Group Incorporated (UNH)147— United Parcel Service, Inc. (UPS)148— Wells Fargo & Company (WFC)149✓ Walgreens Boots Alliance, Inc. (WBA)150— Henry Schein, Inc. (HSIC)151✓ Molina Healthcare, Inc. (MOH)152— Universal Health Services, Inc. (UHS)153
Reciprocity shown where the peer’s own current proxy has been read — each mark is cited in the register to that peer’s filing. A dash means the peer’s current proxy was read and names no reciprocal group including Cigna Group.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Citigroup Inc. | 2025 | Jane Fraser | $1,500,000 | $59,570,800 | $28,600,000 | $0 | $95,757,800 |
| 2 | Wells Fargo & Company | 2025 | Charles Scharf | 2,500,000 | 51,938,278 | 29,988,820 | 0 | 94,522,642 |
| 3 | UnitedHealth Group Incorporated | 2025 | Stephen Hemsley | 596,154 | 0 | 60,000,024 | 0 | 60,938,062 |
| 4 | T-Mobile US, Inc. | 2025 | Srinivasan Gopalan | 861,539 | 27,114,078 | 0 | 3,623,603 | 35,439,421 |
| 5 | Verizon Communications Inc. | 2025 | Daniel Schulman | 375,000 | 32,774,795 | 0 | 937,500 | 34,311,016 |
| 6 | AT&T Inc. | 2025 | John Stankey | 2,400,000 | 19,500,012 | 0 | 6,272,000 | 29,906,872 |
| 7 | FedEx Corporation | 2026 | Rajesh Subramaniam | 1,550,000 | 6,731,364 | 3,715,062 | 10,593,500 | 27,554,018 |
| 8 | HCA Healthcare, Inc. | 2025 | Samuel Hazen | 1,577,815 | 8,474,543 | 8,514,090 | 5,416,732 | 26,456,606 |
| 9 | McKesson Corporation | 2026 | Brian Tyler | 1,591,667 | 17,201,202 | 0 | 4,456,668 | 24,213,044 |
| 10 | United Parcel Service, Inc. | 2025 | Carol Tomé | 1,509,713 | 17,550,546 | 1,358,754 | 2,264,569 | 22,878,788 |
| 11 | Cigna Group | 2025 | David Cordani | 1,600,000 | 13,929,161 | 3,400,019 | 3,200,000 | 22,866,134 |
| 12 | Elevance Health, Inc. | 2025 | Gail Boudreaux | 1,600,000 | 13,440,277 | 4,199,765 | 2,768,000 | 22,582,314 |
| 13 | Cardinal Health, Inc. | 2026 | Jason Hollar | 1,500,000 | 16,259,918 | 0 | 4,278,750 | 22,574,349 |
| 14 | MetLife, Inc. | 2025 | Michel Khalaf | 1,500,000 | 14,797,601 | 0 | 4,600,000 | 22,364,273 |
| 15 | Lowe's Companies, Inc. | 2025 | Marvin Ellison | 1,544,231 | 12,480,467 | 4,262,895 | 3,232,693 | 21,581,889 |
| 16 | CVS Health Corporation | 2025 | J. David Joyner | 1,500,000 | 14,499,931 | 0 | 4,695,900 | 21,214,084 |
| 17 | Centene Corporation | 2025 | Sarah London | 1,473,077 | 15,537,733 | 0 | 2,109,446 | 19,506,298 |
| 18 | Humana Inc. | 2025 | James Rechtin | 1,348,558 | 13,868,141 | 0 | 3,034,740 | 18,757,075 |
| 19 | Molina Healthcare, Inc. | 2025 | Joseph Zubretsky | 1,600,000 | 16,199,988 | 0 | 0 | 18,340,783 |
| 20 | Cencora, Inc. | 2025 | Robert Mauch | 1,350,000 | 12,000,218 | 0 | 4,283,213 | 18,256,227 |
| 21 | DaVita Inc. | 2025 | Javier Rodriguez | 1,500,000 | 11,442,481 | 2,699,982 | 2,089,491 | 18,210,597 |
| 22 | Sysco Corporation | 2026 | Kevin Hourican | 1,435,538 | 10,391,759 | 2,579,986 | 2,905,602 | 17,899,369 |
| 23 | Universal Health Services, Inc. | 2025 | Marc Miller | 1,430,769 | 9,999,904 | 0 | 4,292,307 | 16,148,937 |
| 24 | Quest Diagnostics Incorporated | 2025 | James Davis | 1,250,000 | 8,762,861 | 2,999,873 | 2,205,844 | 15,498,479 |
| 25 | The Kroger Co. | 2025 | Ronald L. Sargent | 3,975,806 | 10,000,077 | — | — | 14,037,608 |
| 26 | Costco Wholesale Corporation | 2025 | Ron Vachris | 1,183,270 | 12,036,800 | 0 | 600,000 | 13,932,597 |
| 27 | Walgreens Boots Alliance, Inc. | 2024 | Timothy Wentworth | 1,290,385 | 11,600,744 | 0 | 0 | 13,282,800 |
| 28 | Henry Schein, Inc. | 2025 | Stanley Bergman | 1,707,000 | 7,764,800 | 0 | 2,289,251 | 12,013,915 |
| 29 | Prudential Financial, Inc. | 2025 | Andrew Sullivan | 1,089,205 | 4,618,266 | 0 | 4,664,000 | 11,408,423 |
| 30 | Target Corporation | 2025 | Michael Fiddelke | 1,065,385 | 7,853,253 | 0 | 300,882 | 9,598,071 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Cigna Group | 100% | PSU 60 · RSU 20 · Options 20 | No | Pay Governance |
| AT&T Inc. | 112% | PSU 75 · RSU 25 | Yes — Relative Total Stockholder Return (TSR) Payout Modifier | Frederic W. Cook & Co., Inc. (FW Cook) |
| Cardinal Health, Inc. | not disclosed | PSU 60 · RSU 40 | Yes — Relative TSR modifier | Korn Ferry |
| Cencora, Inc. | 181.3% | PSU 60 · RSU 40 | Yes — Relative TSR | Pearl Meyer & Partners |
| Centene Corporation | 71.6% | PSU 60 · RSU 40 | Yes — Relative TSR | FW Cook |
| Citigroup Inc. | not disclosed | PSU 50 · RSU 50 | Yes — TSR | FW Cook |
| Costco Wholesale Corporation | 120% | RSU 100 | No | None used (Committee has authority to engage consultants but did not use any) |
| CVS Health Corporation | 156.5% | PSU 60 · RSU 20 · Options 20 | Yes — rTSR Modifier | Korn Ferry |
| DaVita Inc. | 93% | PSU 60 · RSU 20 · Options 20 | Yes — Relative TSR v. S&P Health Care Services Select Industry Index | Compensia |
| Elevance Health, Inc. | 86.5% | PSU 52 · RSU 24 · Options 24 | No | Willis Towers Watson (WTW) |
| FedEx Corporation | 112.5% | not disclosed | Yes — Relative TSR (FY24-FY26 LTI Cash Plan) | Meridian Compensation Partners, LLC |
| HCA Healthcare, Inc. | 195.78% | SAR 50 · PSU 50 | No | Semler Brossy |
| Henry Schein, Inc. | 89.3% | PSU 65 · RSU 35 | No | Pearl Meyer |
| Humana Inc. | 112% | PSU 60 · RSU 40 | Yes — Relative TSR | Farient Advisors, LLC |
| Lowe's Companies, Inc. | 104.67% | PSU 39 · RSA 30 · Stock Options 20 | No | Semler Brossy Consulting Group, LLC |
| McKesson Corporation | 140% | PSU 60 · RSU 40 | Yes — Total Shareholder Return (TSR) relative to comparator group | Korn Ferry |
| MetLife, Inc. | 100.5% | PSU 70 · RSU 30 | Yes — TSR relative to TSR Peer Group | Meridian Compensation Partners, LLC |
| Molina Healthcare, Inc. | not disclosed | PSU 60 · RSU 40 | No | FW Cook |
| Prudential Financial, Inc. | 106% | PSU 75 · RSU 25 | No | FW Cook |
| Quest Diagnostics Incorporated | 113.9% | PSU 50 · RSU 25 · Options 25 | Yes — Relative TSR | Semler Brossy |
| Sysco Corporation | 115.66% | PSU 50 · RSU 30 · Option 20 | No | Semler Brossy |
| T-Mobile US, Inc. | 161% | PSU 50 · RSU 50 | Yes — Relative Total Shareholder Return (RTSR) | Mercer |
| Target Corporation | not disclosed | PSU 60 · PBRSU 40 | No | Semler Brossy |
| The Kroger Co. | 93.84% | not disclosed | Yes — Value creation (iTSR) | Korn Ferry; Meridian Compensation Partners, LLC |
| United Parcel Service, Inc. | 75% | PSU 93 · Options 7 | Yes — Relative Total Shareowner Return (RTSR) | FW Cook |
| UnitedHealth Group Incorporated | not disclosed | PSU 50 · Options 25 · RSU 25 | No | Pay Governance |
| Universal Health Services, Inc. | 200% | RSU 50 · PSU 50 | No | FW Cook |
| Verizon Communications Inc. | 100% | PSU 60 · RSU 40 | Yes — relative total shareholder return (TSR) position compared with the companies in the S&P 100 | Meridian Compensation Partners, LLC |
| Walgreens Boots Alliance, Inc. | not disclosed | RSU 100 | not disclosed | Mercer |
| Wells Fargo & Company | not disclosed | PSU 65 · RSU 35 | Yes — Relative TSR | Meridian Compensation Partners |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-04-22 | 201,746,941 | 17,359,954 | 513,936 | 91.86% | Passed |
| 2025 | 2025-04-23 | 203,552,958 | 25,079,559 | 437,235 | 89.03% | Passed |
| 2024 | 2024-04-24 | 197,173,863 | 39,200,994 | 434,105 | 83.42% | Passed |
| 2023 | 2023-04-26 | 221,436,565 | 29,691,242 | 611,774 | 88.18% | Passed |
| 2022 | 2022-04-22 | 268,038,788 | 48,001,199 | 564,510 | 84.81% | Passed |
| 2021 | 2021-04-28 | 273,770,663 | 22,501,688 | 516,052 | 92.41% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-04-22 | 91.86%a |
| 2025 | 2025-04-23 | 89.03%b |
| 2024 | 2024-04-24 | 83.42%c |
a. Approved under the standard stated in the filing — “2 Advisory approval of executive compensation Majority of shares present and entitled to vote on the subject matter Counted "against" Not voted/No effect”.
b. Approved under the standard stated in the filing — “114 The Cigna Group | 2025 Notice of Annual Meeting of Shareholders and Proxy Statement ANNUAL MEETING INFORMATION Management Proposal / Item Vote Required for Approval Effect of Abstentions Effect of Broker Non-Votes 1 Election of eleven director nominees named in this Proxy Statement Majority of votes cast No effect Not voted/No effect 2 Advisory approval of executive compensation Majority of shares present and entitled to vote on the subject matter Counted "against" Not voted/No effect 3 Ratification of the appointment of the appointment of independent auditor Majority of shares present and entitled to vote on the subject matter Counted "against" No broker non-votes;”.
c. Approved under the standard stated in the filing — “The Cigna Group | 2024 Notice of Annual Meeting of Shareholders and Proxy Statement 131 ANNUAL MEETING INFORMATION Management Proposal / Item Vote Required for Approval Effect of Abstentions Effect of Broker Non-Votes 1 Election of twelve director nominees named in this Proxy Statement Majority of votes cast No effect Not voted/No effect 2 Advisory approval of executive compensation Majority of shares present and entitled to vote on the subject matter Counted "against" Not voted/No effect 3 Ratification of the appointment of the appointment of independent auditor Majority of shares present and entitled to vote on the subject matter Counted "against" No broker non-votes;”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 310 : 1 |
|---|---|
| CEO total compensation | $22,866,134 |
| Median employee compensation | $73,674 |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Michael J. Hennigan | Director | 2026-04-22 | A | 782 | $0 | $0 | Common | Form 4 ↗ |
| Kathleen M. Mazzarella | Director | 2026-04-22 | A | 782 | 0 | 0 | Common | Form 4 ↗ |
| Mark B. McClellan | Director | 2026-04-22 | A | 782 | 0 | 0 | Common | Form 4 ↗ |
| George Kurian | Director | 2026-04-22 | A | 782 | 0 | 0 | Common | Form 4 ↗ |
| Donna F. Zarcone | Director | 2026-04-22 | A | 782 | 0 | 0 | Common | Form 4 ↗ |
| Philip Ozuah | Director | 2026-04-22 | A | 782 | 0 | 0 | Common | Form 4 ↗ |
| Kimberly A. Ross | Director | 2026-04-22 | A | 782 | 0 | 0 | Common | Form 4 ↗ |
| Neesha Hathi | Director | 2026-04-22 | A | 782 | 0 | 0 | Common | Form 4 ↗ |
| Eric J. Foss | Director | 2026-04-22 | A | 782 | 0 | 0 | Common | Form 4 ↗ |
| Eric C. Wiseman | Director | 2026-04-22 | A | 782 | 0 | 0 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 85,519 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 103,595 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 2,231 | 299 | 666,027 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 15,319 | 298 | 4,568,736 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 2,017 | 297 | 598,718 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 34,641 | 296 | 10,253,196 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 38,487 | 295 | 11,352,888 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 2,142 | 294 | 629,575 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 7,861 | 293 | 2,302,311 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 12,315 | 292 | 3,595,314 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 13,732 | 291 | 3,996,089 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 41,099 | 290 | 11,918,784 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 13,839 | 289 | 3,997,456 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 14,292 | 288 | 4,115,590 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 3,903 | 287 | 1,119,505 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | A | 85,519 | 197 | 16,877,175 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | A | 103,595 | 149 | 15,449,640 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-13 | D | 7,971 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-13 | D | 15,458 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-13 | A | 7,971 | 197 | 1,573,077 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-13 | A | 15,458 | 149 | 2,305,329 | Common | Form 4 ↗ |
| George Kurian | Director | 2026-05-29 | A | 108.15 | 277 | 30,000 | Derivative, Class A Common | Form 4 ↗ |
| Durga Prasad Koka | EVP, Global CIO | 2026-06-01 | D | 729 | 276 | 200,861 | Common | Form 4 ↗ |
| Jamie G. Kates | Chief Accounting Officer | 2026-06-12 | D | 899 | 299 | 268,452 | Common | Form 4 ↗ |
| Jamie G. Kates | Chief Accounting Officer | 2026-06-12 | A | 899 | 153 | 137,452 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-06-12 | — | 899 | — | — | 1 insider, 1 accrual row | ||
| Dividend-equivalent accruals | 2026-07-09 | — | 1 | — | ~259 | 1 insider, 1 accrual row | ||
| Dividend-equivalent accruals | 2026-07-23 | — | 1 | — | ~271 | 1 insider, 1 accrual row | ||
| Nicole Jones | See Remarks | 2026-08-04 | D | 14,045 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Nicole Jones | See Remarks | 2026-08-04 | D | 19,436 | 276 | 5,369,584 | Common | Form 4 ↗ |
| Nicole Jones | See Remarks | 2026-08-04 | A | 14,045 | 192 | 2,696,921 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-08-05 | — | 1,301 | — | — | 1 insider, 1 accrual row | ||
| Nicole Jones | See Remarks | 2026-08-05 | A | 1,301 | 192 | 249,818 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-08-06 | — | 1 | — | ~271 | 1 insider, 1 accrual row | ||
| Nicole Jones | See Remarks | 2026-08-18 | D | 2,677 | 280 | 748,516 | Common | Form 4 ↗ |
| George Kurian | Director | 2026-08-31 | A | 108.66 | 276 | 30,000 | Derivative, Class A Common | Form 4 ↗ |
| Brian C. Evanko | See Remarks | 2026-09-01 | A | 6,716 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Brian C. Evanko | See Remarks | 2026-09-01 | A | 3,113 | 0 | 0 | Common | Form 4 ↗ |
| Everett Neville | See Remarks | 2026-09-03 | D | 617 | 284 | 175,259 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
View all 49 transactions
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Michael J. Hennigan | Director | 2026-04-22 | A | 782 | $0 | $0 | Common | Form 4 ↗ |
| Kathleen M. Mazzarella | Director | 2026-04-22 | A | 782 | 0 | 0 | Common | Form 4 ↗ |
| Mark B. McClellan | Director | 2026-04-22 | A | 782 | 0 | 0 | Common | Form 4 ↗ |
| George Kurian | Director | 2026-04-22 | A | 782 | 0 | 0 | Common | Form 4 ↗ |
| Donna F. Zarcone | Director | 2026-04-22 | A | 782 | 0 | 0 | Common | Form 4 ↗ |
| Philip Ozuah | Director | 2026-04-22 | A | 782 | 0 | 0 | Common | Form 4 ↗ |
| Kimberly A. Ross | Director | 2026-04-22 | A | 782 | 0 | 0 | Common | Form 4 ↗ |
| Neesha Hathi | Director | 2026-04-22 | A | 782 | 0 | 0 | Common | Form 4 ↗ |
| Eric J. Foss | Director | 2026-04-22 | A | 782 | 0 | 0 | Common | Form 4 ↗ |
| Eric C. Wiseman | Director | 2026-04-22 | A | 782 | 0 | 0 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 85,519 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 103,595 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 2,231 | 299 | 666,027 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 15,319 | 298 | 4,568,736 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 2,017 | 297 | 598,718 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 34,641 | 296 | 10,253,196 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 38,487 | 295 | 11,352,888 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 2,142 | 294 | 629,575 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 7,861 | 293 | 2,302,311 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 12,315 | 292 | 3,595,314 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 13,732 | 291 | 3,996,089 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 41,099 | 290 | 11,918,784 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 13,839 | 289 | 3,997,456 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 14,292 | 288 | 4,115,590 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | D | 3,903 | 287 | 1,119,505 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | A | 85,519 | 197 | 16,877,175 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-12 | A | 103,595 | 149 | 15,449,640 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-13 | D | 7,971 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-13 | D | 15,458 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-13 | A | 7,971 | 197 | 1,573,077 | Common | Form 4 ↗ |
| David Cordani | Director | 2026-05-13 | A | 15,458 | 149 | 2,305,329 | Common | Form 4 ↗ |
| George Kurian | Director | 2026-05-29 | A | 108.15 | 277 | 30,000 | Derivative, Class A Common | Form 4 ↗ |
| Durga Prasad Koka | EVP, Global CIO | 2026-06-01 | D | 729 | 276 | 200,861 | Common | Form 4 ↗ |
| Jamie G. Kates | Chief Accounting Officer | 2026-06-12 | D | 899 | 299 | 268,452 | Common | Form 4 ↗ |
| Jamie G. Kates | Chief Accounting Officer | 2026-06-12 | A | 899 | 153 | 137,452 | Common | Form 4 ↗ |
| Jamie G. Kates | Chief Accounting Officer | 2026-06-12 | D | 899 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Bryan Holgerson | See Remarks | 2026-07-09 | A | 0.89 | 292 | 259 | Derivative, Class A Common | Form 4 ↗ |
| Bryan Holgerson | See Remarks | 2026-07-23 | A | 0.95 | 286 | 271 | Derivative, Class A Common | Form 4 ↗ |
| Nicole Jones | See Remarks | 2026-08-04 | D | 14,045 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Nicole Jones | See Remarks | 2026-08-04 | D | 19,436 | 276 | 5,369,584 | Common | Form 4 ↗ |
| Nicole Jones | See Remarks | 2026-08-04 | A | 14,045 | 192 | 2,696,921 | Common | Form 4 ↗ |
| Nicole Jones | See Remarks | 2026-08-05 | D | 1,301 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Nicole Jones | See Remarks | 2026-08-05 | A | 1,301 | 192 | 249,818 | Common | Form 4 ↗ |
| Bryan Holgerson | See Remarks | 2026-08-06 | A | 0.98 | 275 | 271 | Derivative, Class A Common | Form 4 ↗ |
| Nicole Jones | See Remarks | 2026-08-18 | D | 2,677 | 280 | 748,516 | Common | Form 4 ↗ |
| George Kurian | Director | 2026-08-31 | A | 108.66 | 276 | 30,000 | Derivative, Class A Common | Form 4 ↗ |
| Brian C. Evanko | See Remarks | 2026-09-01 | A | 6,716 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Brian C. Evanko | See Remarks | 2026-09-01 | A | 3,113 | 0 | 0 | Common | Form 4 ↗ |
| Everett Neville | See Remarks | 2026-09-03 | D | 617 | 284 | 175,259 | Common | Form 4 ↗ |
Sources (153 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, David Cordani. DEF 14A, filed 2026-03-13. Section “2025 Summary Compensation Table” · page 87. As printed: 22,866,134. View filing ↗
- Section 01, Eric Palmer. DEF 14A, filed 2026-03-13. Section “Summary Compensation Table” · page 87. As printed: 12,274,760. View filing ↗
- Section 01, Brian Evanko. DEF 14A, filed 2026-03-13. Section “2025 Summary Compensation Table” · page 87. As printed: 9,998,401. View filing ↗
- Section 01, Nicole Jones. DEF 14A, filed 2026-03-13. Section “2025 Summary Compensation Table” · page 87. As printed: 5,955,936. View filing ↗
- Section 01, Ann Dennison. DEF 14A, filed 2026-03-13. Section “2025 Summary Compensation Table” · page 87. As printed: 4,691,526. View filing ↗
- Section 01, Noelle Eder. DEF 14A, filed 2026-03-13. Section “Summary Compensation Table” · page 87. As printed: 4,312,795. View filing ↗
- Section 01, Everett Neville. DEF 14A, filed 2026-03-13. Section “2025 Summary Compensation Table” · page 87. As printed: 4,073,915. View filing ↗
- Section 03, David Cordani PSU. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 03, Nicole Jones RSU. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 03, Noelle Eder OPTION. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 03, David Cordani RSU. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 03, Everett Neville PSU. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 03, Ann Dennison PSU. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 03, David Cordani OPTION. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 03, Ann Dennison OPTION. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 03, Everett Neville OPTION. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 03, Everett Neville RSU. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 03, Ann Dennison PSU. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 03, Brian Evanko OPTION. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 03, Eric Palmer OPTION. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 03, Ann Dennison RSU. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 03, Noelle Eder PSU. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 03, Brian Evanko RSU. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 03, Nicole Jones OPTION. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 03, Eric Palmer RSU. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 03, Noelle Eder RSU. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 03, Nicole Jones PSU. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 03, Eric Palmer PSU. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 03, Brian Evanko PSU. DEF 14A, filed 2026-03-13. Section “Grants of Plan-Based Awards in” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-03-13. Section “CEO Pay Ratio”. As printed: 310 : 1. View filing ↗
- Section 08, Eric C. Wiseman. DEF 14A, filed 2026-03-13. Section “Director Compensation”. As printed: 410,306. View filing ↗
- Section 08, Elder Granger, M.D. DEF 14A, filed 2026-03-13. Section “Director Compensation”. As printed: 370,306. View filing ↗
- Section 08, Donna F. Zarcone. DEF 14A, filed 2026-03-13. Section “Director Compensation”. As printed: 362,806. View filing ↗
- Section 08, Kimberly A. Ross. DEF 14A, filed 2026-03-13. Section “Director Compensation”. As printed: 362,806. View filing ↗
- Section 08, Eric J. Foss. DEF 14A, filed 2026-03-13. Section “Director Compensation”. As printed: 360,306. View filing ↗
- Section 08, Kathleen M. Mazzarella. DEF 14A, filed 2026-03-13. Section “Director Compensation”. As printed: 360,306. View filing ↗
- Section 08, Neesha Hathi. DEF 14A, filed 2026-03-13. Section “Director Compensation”. As printed: 337,806. View filing ↗
- Section 08, Philip O. Ozuah, M.D., Ph.D. DEF 14A, filed 2026-03-13. Section “Director Compensation”. As printed: 335,306. View filing ↗
- Section 08, George Kurian. DEF 14A, filed 2026-03-13. Section “Director Compensation”. As printed: 335,306. View filing ↗
- Section 08, Mark B. McClellan, M.D., Ph.D. DEF 14A, filed 2026-03-13. Section “Director Compensation”. As printed: 335,306. View filing ↗
- Section 08, Michael J. Hennigan. DEF 14A, filed 2026-03-13. Section “Director Compensation”. As printed: 239,473. View filing ↗
- Section 08, William J. DeLaney. DEF 14A, filed 2026-03-13. Section “Director Compensation”. As printed: 70,094. View filing ↗
- Section 08, Brian C. Evanko. DEF 14A, filed 2026-03-13. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, David M. Cordani. DEF 14A, filed 2026-03-13. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 02, Michael J. Hennigan 2026-04-22. Form 4, filed 2026-04-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kathleen M. Mazzarella 2026-04-22. Form 4, filed 2026-04-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark B. McClellan 2026-04-22. Form 4, filed 2026-04-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, George Kurian 2026-04-22. Form 4, filed 2026-04-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Donna F. Zarcone 2026-04-22. Form 4, filed 2026-04-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Philip Ozuah 2026-04-22. Form 4, filed 2026-04-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kimberly A. Ross 2026-04-22. Form 4, filed 2026-04-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Neesha Hathi 2026-04-22. Form 4, filed 2026-04-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Eric J. Foss 2026-04-22. Form 4, filed 2026-04-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Eric C. Wiseman 2026-04-22. Form 4, filed 2026-04-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Cordani 2026-05-12. Form 4, filed 2026-05-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Cordani 2026-05-12. Form 4, filed 2026-05-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Cordani 2026-05-12. Form 4, filed 2026-05-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Cordani 2026-05-12. Form 4, filed 2026-05-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Cordani 2026-05-12. Form 4, filed 2026-05-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Cordani 2026-05-12. Form 4, filed 2026-05-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Cordani 2026-05-12. Form 4, filed 2026-05-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Cordani 2026-05-12. Form 4, filed 2026-05-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Cordani 2026-05-12. Form 4, filed 2026-05-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Cordani 2026-05-12. Form 4, filed 2026-05-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Cordani 2026-05-12. Form 4, filed 2026-05-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Cordani 2026-05-12. Form 4, filed 2026-05-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Cordani 2026-05-12. Form 4, filed 2026-05-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Cordani 2026-05-12. Form 4, filed 2026-05-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Cordani 2026-05-12. Form 4, filed 2026-05-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Cordani 2026-05-12. Form 4, filed 2026-05-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Cordani 2026-05-12. Form 4, filed 2026-05-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Cordani 2026-05-13. Form 4, filed 2026-05-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Cordani 2026-05-13. Form 4, filed 2026-05-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Cordani 2026-05-13. Form 4, filed 2026-05-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Cordani 2026-05-13. Form 4, filed 2026-05-14. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, George Kurian 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Durga Prasad Koka 2026-06-01. Form 4, filed 2026-06-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jamie G. Kates 2026-06-12. Form 4, filed 2026-06-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jamie G. Kates 2026-06-12. Form 4, filed 2026-06-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jamie G. Kates 2026-06-12. Form 4, filed 2026-06-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bryan Holgerson 2026-07-09. Form 4, filed 2026-08-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bryan Holgerson 2026-07-23. Form 4, filed 2026-08-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Nicole Jones 2026-08-04. Form 4, filed 2026-08-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Nicole Jones 2026-08-04. Form 4, filed 2026-08-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Nicole Jones 2026-08-04. Form 4, filed 2026-08-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Nicole Jones 2026-08-05. Form 4, filed 2026-08-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Nicole Jones 2026-08-05. Form 4, filed 2026-08-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bryan Holgerson 2026-08-06. Form 4, filed 2026-08-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Nicole Jones 2026-08-18. Form 4, filed 2026-08-20. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, George Kurian 2026-08-31. Form 4, filed 2026-09-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Brian C. Evanko 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Brian C. Evanko 2026-09-01. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Everett Neville 2026-09-03. Form 4, filed 2026-09-08. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-04-27. Item 5.07 · say-on-pay result. As reported: 91.86% (votes for as printed: 201,746,941). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-04-28. Item 5.07 · say-on-pay result. As reported: 89.03% (votes for as printed: 203,552,958). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-04-26. Item 5.07 · say-on-pay result. As reported: 83.42% (votes for as printed: 197,173,863). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 1,520,000 + equity 2,329,167 + all other 30,960 = 3,880,127, summed across the director compensation table rows.
- Citigroup Inc., Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in Citigroup Inc.'s own proxy. As printed: 95,757,800. View filing ↗
- Wells Fargo & Company, Section 10b CEO total. DEF 14A, filed 2026-03-18. CEO total compensation as printed in Wells Fargo & Company's own proxy. As printed: 94,522,642. View filing ↗
- UnitedHealth Group Incorporated, Section 10b CEO total. DEF 14A, filed 2026-04-21. CEO total compensation as printed in UnitedHealth Group Incorporated's own proxy. As printed: 60,938,062. View filing ↗
- T-Mobile US, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-27. CEO total compensation as printed in T-Mobile US, Inc.'s own proxy. As printed: 35,439,421. View filing ↗
- Verizon Communications Inc., Section 10b CEO total. DEF 14A, filed 2026-04-06. CEO total compensation as printed in Verizon Communications Inc.'s own proxy. As printed: 34,311,016. View filing ↗
- AT&T Inc., Section 10b CEO total. DEF 14A, filed 2026-03-23. CEO total compensation as printed in AT&T Inc.'s own proxy. As printed: 29,906,872. View filing ↗
- FedEx Corporation, Section 10b CEO total. DEF 14A, filed 2026-08-17. CEO total compensation as printed in FedEx Corporation's own proxy. As printed: 27,554,018. View filing ↗
- HCA Healthcare, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-13. CEO total compensation as printed in HCA Healthcare, Inc.'s own proxy. As printed: 26,456,606. View filing ↗
- McKesson Corporation, Section 10b CEO total. DEF 14A, filed 2026-06-12. CEO total compensation as printed in McKesson Corporation's own proxy. As printed: 24,213,044. View filing ↗
- United Parcel Service, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-19. CEO total compensation as printed in United Parcel Service, Inc.'s own proxy. As printed: 22,878,788. View filing ↗
- Cigna Group (subject), Section 10b CEO total. DEF 14A, filed 2026-03-13. CEO total compensation as printed in Cigna Group's own proxy. As printed: 22,866,134. View filing ↗
- Elevance Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-27. CEO total compensation as printed in Elevance Health, Inc.'s own proxy. As printed: 22,582,314. View filing ↗
- Cardinal Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-09-21. CEO total compensation as printed in Cardinal Health, Inc.'s own proxy. As printed: 22,574,349. View filing ↗
- MetLife, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-29. CEO total compensation as printed in MetLife, Inc.'s own proxy. As printed: 22,364,273. View filing ↗
- Lowe's Companies, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-16. CEO total compensation as printed in Lowe's Companies, Inc.'s own proxy. As printed: 21,581,889. View filing ↗
- CVS Health Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-03. CEO total compensation as printed in CVS Health Corporation's own proxy. As printed: 21,214,084. View filing ↗
- Centene Corporation, Section 10b CEO total. DEF 14A, filed 2026-03-26. CEO total compensation as printed in Centene Corporation's own proxy. As printed: 19,506,298. View filing ↗
- Humana Inc., Section 10b CEO total. DEFR 14A, filed 2026-03-06. CEO total compensation as printed in Humana Inc.'s own proxy. As printed: 18,757,075. View filing ↗
- Molina Healthcare, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-23. CEO total compensation as printed in Molina Healthcare, Inc.'s own proxy. As printed: 18,340,783. View filing ↗
- Cencora, Inc., Section 10b CEO total. DEF 14A, filed 2026-01-22. CEO total compensation as printed in Cencora, Inc.'s own proxy. As printed: 18,256,227. View filing ↗
- DaVita Inc., Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in DaVita Inc.'s own proxy. As printed: 18,210,597. View filing ↗
- Sysco Corporation, Section 10b CEO total. DEF 14A, filed 2026-10-01. CEO total compensation as printed in Sysco Corporation's own proxy. As printed: 17,899,369. View filing ↗
- Universal Health Services, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-09. CEO total compensation as printed in Universal Health Services, Inc.'s own proxy. As printed: 16,148,937. View filing ↗
- Quest Diagnostics Incorporated, Section 10b CEO total. DEF 14A, filed 2026-04-06. CEO total compensation as printed in Quest Diagnostics Incorporated's own proxy. As printed: 15,498,479. View filing ↗
- The Kroger Co., Section 10b CEO total. DEF 14A, filed 2026-05-13. CEO total compensation as printed in The Kroger Co.'s own proxy. As printed: 14,037,608. View filing ↗
- Costco Wholesale Corporation, Section 10b CEO total. DEF 14A, filed 2025-12-04. CEO total compensation as printed in Costco Wholesale Corporation's own proxy. As printed: 13,932,597. View filing ↗
- Walgreens Boots Alliance, Inc., Section 10b CEO total. DEF 14A, filed 2024-12-13. CEO total compensation as printed in Walgreens Boots Alliance, Inc.'s own proxy. As printed: 13,282,800. View filing ↗
- Henry Schein, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-08. CEO total compensation as printed in Henry Schein, Inc.'s own proxy. As printed: 12,013,915. View filing ↗
- Prudential Financial, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-26. CEO total compensation as printed in Prudential Financial, Inc.'s own proxy. As printed: 11,408,423. View filing ↗
- Target Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-27. CEO total compensation as printed in Target Corporation's own proxy. As printed: 9,598,071. View filing ↗
- Section 10a, Citigroup Inc. reciprocity. DEF 14A. Citigroup Inc.'s most recent proxy was read; its disclosed peer group does not include Cigna Group. View filing ↗
- Section 10a, Verizon Communications Inc. reciprocity. DEF 14A. Verizon Communications Inc.'s most recent proxy was read; its disclosed peer group does not include Cigna Group. View filing ↗
- Section 10a, Elevance Health, Inc. reciprocity. DEF 14A. Elevance Health, Inc. names Cigna Group in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, DaVita Inc. reciprocity. DEF 14A. DaVita Inc.'s most recent proxy was read; its disclosed peer group does not include Cigna Group. View filing ↗
- Section 10a, Quest Diagnostics Incorporated reciprocity. DEF 14A. Quest Diagnostics Incorporated's most recent proxy was read; its disclosed peer group does not include Cigna Group. View filing ↗
- Section 10a, T-Mobile US, Inc. reciprocity. DEF 14A. T-Mobile US, Inc.'s most recent proxy was read; its disclosed peer group does not include Cigna Group. View filing ↗
- Section 10a, Lowe's Companies, Inc. reciprocity. DEF 14A. Lowe's Companies, Inc.'s most recent proxy was read; its disclosed peer group does not include Cigna Group. View filing ↗
- Section 10a, Sysco Corporation reciprocity. DEF 14A. Sysco Corporation's most recent proxy was read; its disclosed peer group does not include Cigna Group. View filing ↗
- Section 10a, AT&T Inc. reciprocity. DEF 14A. AT&T Inc.'s most recent proxy was read; its disclosed peer group does not include Cigna Group. View filing ↗
- Section 10a, Cardinal Health, Inc. reciprocity. DEF 14A. Cardinal Health, Inc. names Cigna Group in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Cencora, Inc. reciprocity. DEF 14A. Cencora, Inc. names Cigna Group in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Centene Corporation reciprocity. DEF 14A. Centene Corporation names Cigna Group in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Costco Wholesale Corporation reciprocity. DEF 14A. Costco Wholesale Corporation's most recent proxy was read; its disclosed peer group does not include Cigna Group. View filing ↗
- Section 10a, HCA Healthcare, Inc. reciprocity. DEF 14A. HCA Healthcare, Inc. names Cigna Group in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Humana Inc. reciprocity. DEF 14A. Humana Inc. names Cigna Group in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Prudential Financial, Inc. reciprocity. DEF 14A. Prudential Financial, Inc.'s most recent proxy was read; its disclosed peer group does not include Cigna Group. View filing ↗
- Section 10a, Target Corporation reciprocity. DEF 14A. Target Corporation names Cigna Group in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, UnitedHealth Group Incorporated reciprocity. DEF 14A. UnitedHealth Group Incorporated names Cigna Group in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, United Parcel Service, Inc. reciprocity. DEF 14A. United Parcel Service, Inc.'s most recent proxy was read; its disclosed peer group does not include Cigna Group. View filing ↗
- Section 10a, Wells Fargo & Company reciprocity. DEF 14A. Wells Fargo & Company's most recent proxy was read; its disclosed peer group does not include Cigna Group. View filing ↗
- Section 10a, Walgreens Boots Alliance, Inc. reciprocity. DEF 14A. Walgreens Boots Alliance, Inc. names Cigna Group in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Henry Schein, Inc. reciprocity. DEF 14A. Henry Schein, Inc.'s most recent proxy was read; its disclosed peer group does not include Cigna Group. View filing ↗
- Section 10a, Molina Healthcare, Inc. reciprocity. DEF 14A. Molina Healthcare, Inc. names Cigna Group in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Universal Health Services, Inc. reciprocity. DEF 14A. Universal Health Services, Inc.'s most recent proxy was read; its disclosed peer group does not include Cigna Group. View filing ↗